All Stories

  1. Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy

    Article • Annals of Neurology, March 2024, Wiley

    FEDERICO MASSA

  2. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages

    Article • Cortex, February 2024, Elsevier

    FEDERICO MASSA

  3. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era

    Article • European Journal of Nuclear Medicine and Molecular Imaging, January 2024, Springer Science + Business Media

    FEDERICO MASSA

  4. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome

    Article • Neurological Sciences, January 2024, Springer Science + Business Media

    FEDERICO MASSA

  5. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease

    Article • Journal of Neurology, December 2023, Springer Science + Business Media

    FEDERICO MASSA

  6. Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to Alzheimer’s disease

    Article • Cerebral Cortex, August 2023, Oxford University Press (OUP)

    FEDERICO MASSA

  7. CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease

    Article • Neurology, May 2023, Wolters Kluwer Health

    FEDERICO MASSA

  8. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort

    Article • Neurological Sciences, May 2023, Springer Science + Business Media

    FEDERICO MASSA

  9. Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment

    Article • Journal of Alzheimer s Disease, May 2023, IOS Press

    FEDERICO MASSA

  10. Right posterior hypometabolism in Pisa syndrome of Parkinson’s disease: A key to explain body schema perception deficit?

    Article • Parkinsonism & Related Disorders, May 2023, Elsevier

    FEDERICO MASSA

  11. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)

    Article • European Journal of Nuclear Medicine and Molecular Imaging, December 2022, Springer Science + Business Media

    FEDERICO MASSA

  12. Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements

    Article • Physica Medica, November 2022, Elsevier

    FEDERICO MASSA

  13. Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy

    Article • Journal of Alzheimer s Disease, October 2022, IOS Press

    FEDERICO MASSA

  14. European consensus for the diagnosis of MCI and mild dementia: Preparatory phase

    Article • Alzheimer s & Dementia, October 2022, Wiley

    Dr Alexander Haliassos, FEDERICO MASSA

  15. Derivation and Validation of a Phenoconversion‐Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder

    Article • Movement Disorders, October 2022, Wiley

    FEDERICO MASSA

  16. A case of Huntington disease‐like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era

    Article • Clinical Case Reports, October 2022, Wiley

    FEDERICO MASSA

  17. The Role of Monoaminergic Tones and Brain Metabolism in Cognition in De Novo Parkinson’s Disease

    Article • Journal of Parkinson s Disease, September 2022, IOS Press

    FEDERICO MASSA

  18. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments

    Article • Neurological Sciences, August 2022, Springer Science + Business Media

    FEDERICO MASSA

  19. Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer’s disease

    Article • Journal of Neurology Neurosurgery & Psychiatry, August 2022, BMJ

    FEDERICO MASSA

  20. Epileptic phenotypes in autoimmune encephalitis: from acute symptomatic seizures to autoimmune-associated epilepsy

    Article • Journal of Neurology Neurosurgery & Psychiatry, July 2022, BMJ

    FEDERICO MASSA

  21. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain–Barré Syndrome Following an Antecedent Parainfectious COVID-19–Related GBS

    Article • Frontiers in Immunology, July 2022, Frontiers

    FEDERICO MASSA

  22. Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease

    Article • International Journal of Molecular Sciences, June 2022, MDPI AG

    FEDERICO MASSA

  23. Neurological long-COVID in the outpatient clinic: Two subtypes, two courses

    Article • Journal of the Neurological Sciences, June 2022, Elsevier

    FEDERICO MASSA

  24. The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort

    Article • Journal of Alzheimer s Disease, May 2022, IOS Press

    FEDERICO MASSA

  25. Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data

    Article • Neurobiology of Aging, May 2022, Elsevier

    FEDERICO MASSA

  26. The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia

    Article • Biomedicines, February 2022, MDPI AG

    FEDERICO MASSA

  27. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease

    Article • European Journal of Nuclear Medicine and Molecular Imaging, October 2021, Springer Science + Business Media

    FEDERICO MASSA

  28. Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson’s Disease

    Article • Neurological Sciences, September 2021, Springer Science + Business Media

    FEDERICO MASSA

  29. Stratification Tools for Disease‐Modifying Trials in Prodromal Synucleinopathy

    Article • Movement Disorders, September 2021, Wiley

    FEDERICO MASSA

  30. Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature

    Article • Journal of the Neurological Sciences, September 2021, Elsevier

    FEDERICO MASSA

  31. Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration

    Article • Journal of Neural Transmission, August 2021, Springer Science + Business Media

    FEDERICO MASSA

  32. A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection

    Article • Journal of Neuroimmunology, August 2021, Elsevier

    FEDERICO MASSA

  33. Dopaminergic and Serotonergic Degeneration and Cortical [ 18 F ]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease

    Article • Movement Disorders, May 2021, Wiley

    FEDERICO MASSA

  34. Brain Metabolic Correlates of Persistent Olfactory Dysfunction after SARS-Cov2 Infection

    Article • Biomedicines, March 2021, MDPI AG

    FEDERICO MASSA

  35. FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration

    Article • Clinical Nuclear Medicine, February 2021, Wolters Kluwer Health

    FEDERICO MASSA

  36. Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients

    Article • European Journal of Nuclear Medicine and Molecular Imaging, January 2021, Springer Science + Business Media

    FEDERICO MASSA

  37. Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD)

    Article • Diagnostics, January 2021, MDPI AG

    FEDERICO MASSA

  38. Sex differences in neuroimaging biomarkers in healthy subjects and dementia

    Article • January 2021, Elsevier

    FEDERICO MASSA

  39. Rapid eye movement sleep behavior disorder: A proof‐of‐concept neuroprotection study for prodromal synucleinopathies

    Article • European Journal of Neurology, December 2020, Wiley

    FEDERICO MASSA

  40. Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools

    Article • EJNMMI Research, November 2020, Springer Science + Business Media

    FEDERICO MASSA

  41. Neuroimaging Findings in Mild Cognitive Impairment

    Article • October 2020, Springer Science + Business Media

    FEDERICO MASSA

  42. Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease

    Article • Cortex, September 2020, Elsevier

    FEDERICO MASSA

  43. The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease

    Article • Neurobiology of Aging, September 2020, Elsevier

    FEDERICO MASSA

  44. Utility of quantitative EEG in early Lewy body disease

    Article • Parkinsonism & Related Disorders, June 2020, Elsevier

    FEDERICO MASSA

  45. Bendamustine–rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy

    Article • Journal of the Neurological Sciences, June 2020, Elsevier

    FEDERICO MASSA

  46. Brain Aging, Cardiovascular Diseases, Mixed Dementia, and Frailty in the Oldest Old: From Brain Phenotype to Clinical Expression

    Article • Journal of Alzheimer s Disease, May 2020, IOS Press

    FEDERICO MASSA, de fiammetta monacelli

  47. Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study

    Article • European Journal of Neurology, April 2020, Wiley

    FEDERICO MASSA

  48. Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study

    Article • Journal of Alzheimer s Disease, February 2020, IOS Press

    Dario Arnaldi, FEDERICO MASSA

  49. The fate of patients with REM sleep behavior disorder and mild cognitive impairment

    Article • Sleep Medicine, February 2020, Elsevier

    FEDERICO MASSA

  50. Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia

    Article • American Journal of Geriatric Psychiatry, December 2019, Elsevier

    FEDERICO MASSA

  51. Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years

    Article • Journal of Neuroimmunology, December 2019, Elsevier

    FEDERICO MASSA

  52. Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer’s Disease and Inconclusive First Biomarker

    Article • Journal of Alzheimer s Disease, October 2019, IOS Press

    FEDERICO MASSA

  53. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study

    Article • Neurological Sciences, October 2019, Springer Science + Business Media

    FEDERICO MASSA

  54. Serum neurofilament light chain rate of change in Alzheimer’s disease: potentials applications and notes of caution

    Article • Annals of Translational Medicine, July 2019, AME Publishing Company

    FEDERICO MASSA

  55. Could arterial spin labelling perfusion imaging uncover the invisible in N ‐methyl‐ d ‐aspartate receptor encephalitis?

    Article • European Journal of Neurology, May 2019, Wiley

    FEDERICO MASSA

  56. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI

    Article • Neurobiology of Aging, April 2019, Elsevier

    FEDERICO MASSA

  57. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer’s Disease

    Article • Journal of Alzheimer s Disease, March 2019, IOS Press

    FEDERICO MASSA

  58. 18F-FDG-PET/CT (FDG-PET) in Neurodegenerative Disease

    Article • January 2019, Springer Science + Business Media

    FEDERICO MASSA

  59. Increased incidence of axonal Guillain‐Barré syndrome in La Spezia area of Italy: A 13‐year follow‐up study

    Article • Journal of the Peripheral Nervous System, December 2018, Wiley

    FEDERICO MASSA

  60. N-methyl-d-aspartate receptor antibody-related pathologies and pre-existent mental state disorders

    Article • Schizophrenia Research, December 2018, Elsevier

    FEDERICO MASSA

  61. Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease

    Article • European Journal of Nuclear Medicine and Molecular Imaging, October 2018, Springer Science + Business Media

    FEDERICO MASSA, Professor of Clinical Psychiatry Adrian PREDA

  62. Getting the high school diploma with only one hemisphere: a case report

    Article • Neurological Sciences, August 2018, Springer Science + Business Media

    FEDERICO MASSA

  63. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)

    Article • Alzheimer s Research & Therapy, April 2018, Springer Science + Business Media

    FEDERICO MASSA

  64. Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier

    Article • Cerebellum & Ataxias, March 2018, Springer Science + Business Media

    FEDERICO MASSA

  65. Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers

    Article • Movement Disorders, November 2017, Wiley

    Dr Fabrizio De Carli, Dario Arnaldi, FEDERICO MASSA

  66. Clinical utility and research frontiers of neuroimaging in movement disorders

    Article • The Quarterly Journal of Nuclear Medicine and Molecular Imaging, September 2017, Edizioni Minerva Medica

    FEDERICO MASSA